154 results on '"i̇matinib mesylate"'
Search Results
2. New Research on Gastrointestinal Stromal Tumors from UPMC Hillman Cancer Center Summarized [Differential antitumor activity of compounds targeting the ubiquitin-proteasome machinery in gastrointestinal stromal tumor (GIST) cells]
3. Zydusgets US FDA marketing approval for imatinib mesylate tablets
4. Studies from Osaka University Graduate School of Medicine in the Area of BCR-ABL Tyrosine Kinase Inhibitors Reported (TAS-116 inhibits oncogenic KIT signalling on the Golgi in both imatinib-naive and imatinib-resistant gastrointestinal stromal ...)
5. Researchers from Affiliated Hospital of Guizhou Medical University Detail Findings in Chronic Myeloid Leukemia (Correction of Bcl-x splicing improves responses to imatinib in chronic myeloid leukaemia cells and mouse models)
6. Investigators at Sichuan University Have Reported New Data on Gastrointestinal Stromal Tumors (Preoperative imatinib treatment in patients with locally advanced and metastatic/recurrent gastrointestinal stromal tumors: A single-center analysis)
7. Data from University of Tanta Provide New Insights into Cancer (Targeting MDR-1 gene expression, BAX/BCL2, caspase-3, and Ki-67 by nanoencapsulated imatinib and hesperidin to enhance anticancer activity and ameliorate cardiotoxicity)
8. Reports on Chronic Myeloid Leukemia Findings from University of Utah Provide New Insights (Cost effectiveness of therapeutic drug monitoring for imatinib administration in chronic myeloid leukemia)
9. New Findings in Gastrointestinal Stromal Tumors Described from Sichuan University (Preoperative imatinib treatment in patients with locally advanced and metastatic/recurrent gastrointestinal stromal tumors: A single-center analysis)
10. Studies from Faculty of Medicine University of Indonesia Provide New Data on Health and Medicine [The Role of STAT5 in Tyrosine Kinase Inhibitor (IMATINIB) Resistance in CML Patients]
11. New Findings from University of Tanta in the Area of Ehrlich Carcinoma Described (Enhanced anticancer activity of combined treatment of imatinib and dipyridamole in solid Ehrlich carcinoma-bearing mice)
12. Studies Conducted at University of Tours on Acute Myeloid Leukemia Recently Reported (A Novel Inhibitor of STAT5 Signaling Overcomes Chemotherapy Resistance in Myeloid Leukemia Cells)
13. Reports Outline Cancer Study Findings from Sapienza University (Hybrid Clustered Nanoparticles for Chemo-Antibacterial Combinatorial Cancer Therapy)
14. Investigators at First Affiliated Hospital of Soochow University Zero in on Chronic Myeloid Leukemia (Oncogenic heterogeneous nuclear ribonucleoprotein D-like modulates the growth and imatinib response of human chronic myeloid leukemia CD34+ ...)
15. New Findings on Toxicology Described by Investigators at University of Leeds (Receptor Tyrosine Kinase Inhibitors Cause Dysfunction In Adult Rat Cardiac Fibroblasts In Vitro)
16. Research Data from Department of Laboratory Medicine Update Understanding of Chronic Myeloid Leukemia (Cysteine-rich protein 61 regulates the chemosensitivity of chronic myeloid leukemia to imatinib mesylate through the nuclear factor kappa ...)
17. Research Study Findings from Research Center for Hematology Update Understanding of Chronic Myelogenous Leukemia (The case of successful therapy with Nilotinib in patients with Ph-positive chronic myelogenous leukemia of chronic phase resistant...).
18. Development of plasma cell leukemia in a patient with chronic myeloid leukemia while on treatment with imatinib mesylate
19. Dr Reddy's Labs launches generic Gleevec tablets in US market
20. Findings from Stanford University School of Medicine Has Provided New Information about BCR-ABL Tyrosine Kinase Inhibitors (The tyrosine kinase inhibitor imatinib mesylate suppresses uric acid crystal-induced acute gouty arthritis in mice)
21. Mylan Launches Generic Gleevec[R] Tablets
22. Recent Findings from R. Sanctis and Co-Authors Provide New Insights into BCR-ABL Tyrosine Kinase Inhibitors (Imatinib mesylate in desmoplastic small round cell tumors)
23. Studies from National Cancer Institute Describe New Findings in Gleevec Therapy [Imatinib mesylate (Gleevec) inhibits Notch and c-Myc signaling: Five-day treatment permanently rescues mammary development]
24. Tumeurs stromales gastro-intestinales (GIST).
25. Investigators from University of Turin Report New Data on Interstitial Lung Disease (Successful treatment of gemcitabine-induced acute interstitial pneumonia with imatinib mesylate: a case report)
26. Patent Issued for Process for the Preparation of Amorphous Imatinib Mesylate (USPTO 9439903)
27. Teva Announces Launch of Generic Gleevec[R] Tablets in the United States
28. Sun Pharma Extends Imatinib Mesylate Savings Card Program Benefits for Patients in USA
29. Studies from Shenyang Pharmaceutical University Provide New Data on Imatinib Therapy [The metal-organic framework MIL-101(Cr) as efficient adsorbent in a vortex-assisted dispersive solid-phase extraction of imatinib mesylate in rat plasma ...]
30. Findings from H.Y. Yhim and Co-Researchers in the Area of Myeloid Leukemia Described (Long-Term Outcomes after Imatinib Mesylate Discontinuation in Chronic Myeloid Leukemia Patients with Undetectable Minimal Residual Disease)
31. Investigators from Central Hospital Zero in on Apoptosis (Imatinib mesylate induces mitochondria-dependent apoptosis and inhibits invasion of human pigmented villonodular synovitis fibroblast-like synovial cells)
32. Pearls for managing care of high-risk uveal melanoma patients: Physicians turning to sunitinib as part of increasing efforts in adjuvant treatment
33. Reports from Jawaharlal Institute of Post Graduate Medical Education and Research Provide New Insights into Myeloid Leukemia (A study to explore the correlation of ABCB1, ABCG2, OCT1 genetic polymorphisms and trough level concentration with ...)
34. Investigators at Southern Medical University Zero in on Chronic Myelogenous Leukemia (Inhibition of human chronic myelogenous leukemia K562 cell growth following combination treatment with resveratrol and imatinib mesylate)
35. * Teva launches generic Gleevec tabs
36. Dasatinib in paediatric chronic myeloid leukaemias.
37. Targeted therapy: Generic imatinib - impact on frontline and salvage therapy for CML.
38. Ponatinib circumvents FGF2-driven resistance to imatinib in CML.
39. [STAT5, a new therapeutic target against the relapse of chronic myelogenous leukemia?].
40. Patent watch: Indian Supreme Court blocks Novartis’ Glivec patent.
41. Supreme Court of India rejects Novartis’ cancer drug patent.
42. India's patent case victory rattles Big Pharma.
43. Indian Supreme Court rejects Novartis's appeal on drug patent.
44. As leukemia options grow, drugs jockey to be first-line therapies.
45. Drugmakers struggle with Indian patents.
46. Big Pharma vs India’s Patent Office.
47. Final hearings begin in epic legal battle over Novartis drug in India.
48. NICE backs leukaemia drug after manufacturer drops price.
49. FDA updates Gleevec label for GIST patients.
50. NICE guidance on dasatinib, high-dose imatinib, and nilotinib for patients with CML who are resistant or intolerant to imatinib.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.